NCT07357727 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) Status RECRUITING Phase PHASE3
NCT07357441 A Study to Evaluate the Demographics and Treatment Patterns of Myelofibrosis Patients Treated With Ruxolitinib in Turkey Status COMPLETED Phase N/A
NCT07354074 Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP Status RECRUITING Phase PHASE2
NCT07340190 A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies Status NOT_YET_RECRUITING Phase PHASE1
NCT07340138 Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis Status RECRUITING Phase PHASE1
NCT07326709 A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease Status RECRUITING Phase PHASE3
NCT07290270 Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN) Status RECRUITING Phase N/A
NCT07288359 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07261631 Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT07249463 Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults Status RECRUITING Phase PHASE2
NCT07243782 Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea Status RECRUITING Phase N/A
NCT07243002 Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters. Status RECRUITING Phase N/A
NCT07235059 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease Status RECRUITING Phase PHASE1
NCT07235033 Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2) Status COMPLETED Phase PHASE2